Testing The Limits? FDA Drugs Of Abuse Guidance Draws Mixed Reaction
This article was originally published in The Gray Sheet
Executive Summary
On-site testing manufacturers once again are questioning FDA's regulatory authority regarding on-site drugs of abuse tests intended for non-medical purposes